X
Search
X

Patient Support Hotline

Call (844) 244-1309

ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.

X

Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

  • Patient Support (844) 244-1309
  • Search
  • e-News Signup Enews Signup
  • Run/Walk
  • Donate

Prebiopsy MRI can ‘transform’ prostate cancer care, study finds

Prebiopsy multiparametric MRI (mpMRI) paired with targeted biopsy can improve the detection of clinically significant prostate cancer, according to a study published in JAMA Network Open.

Identifying high-risk from low-risk prostate cancers can spare men from unnecessary invasive treatments and treatment-associated morbidity, wrote first author Martha M. C. Elwenspoek, PhD, but doing so remains difficult.

“There is, therefore, an unmet clinical need to develop tests that can detect clinically significant PCa (csPCa) while reducing overdiagnosis of low-risk disease,” Elwenspoek, with the University of Bristol in the UK, and colleagues noted.

Read the full article here.

source: Matt O'Connor - Health Imaging